<< CSR 1975-2010 Home

The navigation below allows you to jump to any table or figure within the SEER Cancer Statistics Review.

  1. First select the CSR Section, then a Table/Figure from that section.
  2. Use the Submit button to view the table or figure. You will have options to download a printer-friendly version or the data table (CSV) as well.

To learn more about the Cancer Statistics Review and the statistics presented in this report, refer to the About the CSR (PDF, 85 KB) and Technical Notes (PDF, 282 KB) pages.


Download and Print: Download Printer-friendly PDF Download data

Table 32.7

Age-Adjusted SEER Incidencea , by Year and Sex

By Adapted Classification Scheme for Tumors of Adolescents and Young Adultsb

All Races, Ages 15-19

Both Sexes
Site 1975-2010 2001-2010
Count Rate AAPCc Count Rate AAPCc
All Sites Combined 13,416 20.3 0.5* 4,254 21.7 0.5*
1. Leukemias 1,597 2.4 0.8* 538 2.7 0.8*
2. Lymphomas 3,355 5.1 0.0 978 5.0 0.0
3. CNS, intracranial, intraspinal 1,301 2.0 0.3 398 2.0 0.3
4. Osseous & chondromatous nepolasms 1,043 1.6 0.6 330 1.7 0.6
5. Soft tissue sarcomas 981 1.5 0.3 298 1.5 0.3
6. Germ cell and trophoblastic neoplasms 1,635 2.5 0.9* 542 2.8 0.9*
7. Melanoma and skin carcinomas 999 1.5 0.9* 336 1.7 0.9*
8. Carcinomas (excluding skin) 2,246 3.4 1.1* 765 3.9 1.1*
9. Miscellaneous specified neoplasms, NOS 204 0.3 -0.2 62 0.3 -0.2
10. Unspecified malignant neoplasms 55 0.1 - - - -
Males
Site 1975-2010 2001-2010
Count Rate AAPCc Count Rate AAPCc
All Sites Combined 7,056 20.9 0.6* 2,279 22.6 0.6*
1. Leukemias 951 2.8 -1.7 308 3.1 -8.4
2. Lymphomas 1,796 5.3 0.2 541 5.4 0.2
3. CNS, intracranial, intraspinal 755 2.2 0.3 234 2.3 0.3
4. Osseous & chondromatous nepolasms 679 2.0 0.7 209 2.1 0.7
5. Soft tissue sarcomas 514 1.5 1.1 158 1.6 -4.3
6. Germ cell and trophoblastic neoplasms 1,191 3.5 1.2* 415 4.1 1.2*
7. Melanoma and skin carcinomas 398 1.2 1.2* 139 1.4 1.2*
8. Carcinomas (excluding skin) 656 1.9 1.5* 244 2.4 1.5*
9. Miscellaneous specified neoplasms, NOS 91 0.3 - 27 0.3 -
10. Unspecified malignant neoplasms 25 0.1 - - - -
Females
Site 1975-2010 2001-2010
Count Rate AAPCc Count Rate AAPCc
All Sites Combined 6,360 19.7 0.4* 1,975 20.7 0.4*
1. Leukemias 646 2.0 1.4* 230 2.4 1.4*
2. Lymphomas 1,559 4.8 -0.1 437 4.6 -0.1
3. CNS, intracranial, intraspinal 546 1.7 0.1 164 1.7 0.1
4. Osseous & chondromatous nepolasms 364 1.1 0.4 121 1.3 0.4
5. Soft tissue sarcomas 467 1.4 0.5 140 1.5 0.5
6. Germ cell and trophoblastic neoplasms 444 1.4 0.1 127 1.3 0.1
7. Melanoma and skin carcinomas 601 1.9 0.6 197 2.1 0.6
8. Carcinomas (excluding skin) 1,590 4.9 0.9* 521 5.5 0.9*
9. Miscellaneous specified neoplasms, NOS 113 0.3 - 35 0.4 -
10. Unspecified malignant neoplasms 30 0.1 - - - -

Footnotes:

Rates are per 100,000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130).

a Rates are from the SEER 9 areas (San Francisco, Connecticut, Detroit, Hawaii, Iowa, New Mexico, Seattle, Utah, Atlanta).

b Adapted from: RD Barr, EJ Holowaty, JM Birch. Classification Scheme for tumors diagnosed in adolescents and young adults. Cancer. 106:7; 1425-1430. (Restricted to malignant tumors and updated based on ICD-O-3 definitions).

c The AAPC is the Average Annual Percent Change and is based on the APCs calculated by Joinpoint over the time range of 1975-2010.

- Statistic could not be calculated. Count and rate based on less than 16 cases for the time interval. AAPC could not be calculated due to insufficient data.

* The AAPC is significantly different from zero (p<.05).

Page Navigation: << Previous Next >>

The information on this page is archived and provided for reference purposes only. Persons with disabilities having difficulty accessing information on this page may e-mail for assistance.